CRDN

Views & Analysis

The lessons that can be learned for the future of drug development from the collaboration and innovation in this space.

Views & Analysis

CRDN wants to break down barriers in communication between rare disease patients, HCPs and industry.

News

A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.